Norgine buys rights to sell Shield’s iron deficiency therapy
admin 19th September 2018 Uncategorised 0Norgine has signed a deal with Shield Therapeutics allowing it to commercialise iron deficiency therapy Feraccru in Europe, Australia and New Zealand. More: Norgine buys rights to sell Shield’s iron deficiency therapy Source: News
read more